![PreciseDX logo](https://0to5.com/wp-content/uploads/2024/05/PreciseDx.logo_.RGB_210311.png)
PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease analysis. Combining AI with their patented Morphology Feature Array® (MFA), PreciseDx provides highly accurate, actionable intelligence and disease insights that support better decision-making throughout the cancer care continuum.
Objectives
- Increase awareness and visibility of PreciseDx
- Drive thought leadership through subject matter expert’s POV on key industry topics: AI in healthcare, pathology/oncology innovation, etc
- Communicate scientifically-proven superiority over the standard of care and deliver key product messages, highlighting accuracy, timeliness, and cost-effectiveness
- Promote PreciseBreast™ as the new standard in assessing cancer risk of recurrence
2023 Results
53
articles
including: Fierce Healthcare, Fierce Biotech, Fierce Pharma, The Pathologist, WSJ Venture Capital, Forbes, Precision Medicine Online, Healthcare IT News, BioWorld MedTech, Clinical Lab Products, 360Dx, BioSpace, and Lab Pulse, among others
![logo--cpmo_0](https://0to5.com/wp-content/uploads/2024/05/logo-cpmo_0.png)
![TP-logo](https://0to5.com/wp-content/uploads/2024/05/TP-logo.png)
![Fierce-Biotech-Color](https://0to5.com/wp-content/uploads/2024/05/Fierce-Biotech-Color.png)
![Venture-Capital](https://0to5.com/wp-content/uploads/2024/05/Venture-Capital.png)
![clp_d2089bdcb8](https://0to5.com/wp-content/uploads/2024/05/clp_d2089bdcb8-e1717597782722.png)
![GU982b9o_400x400](https://0to5.com/wp-content/uploads/2024/05/GU982b9o_400x400-e1717597807496.png)
media impressions
99M+
media interviews to
build relationships
11
byline articles highlighting
thought leadership
7
Social media impressions
31,223
grew LinkedIn account
from 418 followers to
1,231
Website & Collateral
![Group 28864](https://0to5.com/wp-content/uploads/2024/05/Group-28864.png)
![Group 28866](https://0to5.com/wp-content/uploads/2024/05/Group-28866.png)
![Group 28862](https://0to5.com/wp-content/uploads/2024/05/Group-28862.png)
![Group 28865](https://0to5.com/wp-content/uploads/2024/05/Group-28865.png)
![Group 28854](https://0to5.com/wp-content/uploads/2024/05/Group-28854.png)
![Group 28861](https://0to5.com/wp-content/uploads/2024/05/Group-28861.png)
Media Highlights
![Group 28847](https://0to5.com/wp-content/uploads/2024/05/Group-28847.png)
![Group 28856](https://0to5.com/wp-content/uploads/2024/05/Group-28856.png)
![Group 28846](https://0to5.com/wp-content/uploads/2024/05/Group-28846.png)
![Group 28860](https://0to5.com/wp-content/uploads/2024/05/Group-28860.png)
![Group 28868](https://0to5.com/wp-content/uploads/2024/05/Group-28868.png)
![Group 28867](https://0to5.com/wp-content/uploads/2024/05/Group-28867.png)